Therapeutic Expertise
State-of-the-art technologies
Deep clinical and regulatory expertise
Focused on Diabetes, Obesity, NAFLD/NASH
Therapeutic Expertise

Connecting

Connecting scientific expertise, metabolic focus and advanced methodologies with full scope CRO services to generate highly conclusive study data and support the decision making milestones of our clients.

Diabetes

ProSciento is at the forefront of global drug and device development for diabetes and diabetes-related complications and disorders. Our long-standing commitment to innovation has yielded a unique portfolio of therapeutically focused services, clinical research methods and capabilities to enable effective, comprehensive, and highly informative evaluation of investigational diabetes drugs.

Learn more about ProSciento’s unparalleled expertise and experience in diabetes... READ MORE »

NAFLD/NASH

ProSciento is quickly emerging as a specialized partner and leading service provider in NAFLD/NASH clinical research and development, complemented by our deep experience and expertise in diabetes and obesity. Through our global network of partners, collaborators and specialized service providers, we are offering an integrated portfolio of today’s most advanced imaging techniques and circulating biomarkers to support the development of many promising drug candidates for NAFLD/NASH.

Learn more about ProSciento’s state-of-the-art biomarker and imaging methods to address NAFLD/NASH... READ MORE »

Obesity

The team at ProSciento has decades of experience in obesity drug development, including research, clinical trial design, clinical development and regulatory strategy and interactions. The company employs advanced methodologies to assess body composition, body fat distribution, food intake, energy metabolism and adipose tissue function, as well as innovative study design strategies to address the complexities of subject recruitment and retention for weight-loss trials.

Learn more about ProSciento’s long-standing expertise in obesity... READ MORE »